Skip to main content
Top

Open Access 07-05-2024 | Sclerotherapy | Review Article

Surgery versus sclerotherapy versus combined therapy in head and neck lymphatic malformations in the pediatric population: systematic review and meta-analysis

Authors: Jurriën L. A. Embrechts, Steven Hiddinga, Joseph C. Bot, Jan-Jaap Hendrickx, Rik van Eekelen, Johannes C. F. Ket, C. René Leemans, Remco de Bree

Published in: European Archives of Oto-Rhino-Laryngology

Login to get access

Abstract

Purpose

To systematically review current literature on the treatment of lymphatic malformations (LMs) of the head and neck to guide treatment strategy.

Methods and materials

A systematic review and meta-analysis of literature until 16 November 2021 was performed on treatments of LMs in the head and neck.

Results

Out of 9044 articles, 54 studies were eligible for inclusion with 26 studies providing detailed participant data. A total number of 1573 patients with a mean age of 21.22 months were analysed. Comparative meta-analysis did not reveal significant differences two proportions of volume reduction (≥ 50% and 100%) between sclerotherapy and surgical treatment. Regression demonstrated that positive predictors for volume reduction were surgery 17 (95% CI 0.26–34; p = 0.047) and treatment of macrocystic lesions 19 (95% CI 5.5–32; p = 0.006). Treatment of mixed lesions also demonstrated a trend towards achieving a greater volume reduction (p = 0.052). A higher de Serres stage of the lesion had a negative effect on the amount of volume reduction − 3.7 (95% CI − 7.0 to − 0.35; p = 0.030).

Conclusion

This comprehensive meta-analysis demonstrated no significant difference in volume reduction between various treatment modalities at study level. However, individual patient data indicated that surgery and larger cyst types are associated with a significant higher percentage of volume reduction, whereas a higher de Serres stage negatively impacted the amount of volume reduction. These findings can be used for patient counseling and treatment planning based on cyst type and de Serres stage. However volume reduction constitutes just one objective within a more complex treatment spectrum.
Appendix
Available only for authorised users
Literature
3.
go back to reference ISSVA Classification of Vascular Anomalies ©2018 International society for the Study of vascular anomalies. Available at "issva.org/classification". Accessed 6 Apr 2021 ISSVA Classification of Vascular Anomalies ©2018 International society for the Study of vascular anomalies. Available at "issva.org/classification". Accessed 6 Apr 2021
8.
go back to reference Miceli A, Stewart KM (2022) Lymphangioma. In: StatPearls. StatPearls Publishing, Treasure Island Miceli A, Stewart KM (2022) Lymphangioma. In: StatPearls. StatPearls Publishing, Treasure Island
12.
go back to reference Emery PJ, Bailey CM, Evans JN (1984) Cystic hygroma of the head and neck. A review of 37 cases. J Laryngol Otol 98:613–619CrossRefPubMed Emery PJ, Bailey CM, Evans JN (1984) Cystic hygroma of the head and neck. A review of 37 cases. J Laryngol Otol 98:613–619CrossRefPubMed
18.
go back to reference Mulliken JB, Burrows PE, Fishman SJ, Mulliken JB (2013) Mulliken and Young’s vascular anomalies: Hemangiomas and malformations, 2nd edn. Oxford University Press, OxfordCrossRef Mulliken JB, Burrows PE, Fishman SJ, Mulliken JB (2013) Mulliken and Young’s vascular anomalies: Hemangiomas and malformations, 2nd edn. Oxford University Press, OxfordCrossRef
32.
go back to reference Smith MC, Zimmerman MB, Burke DK et al (2009) Efficacy and safety of OK-432 immunotherapy of lymphatic malformations. Laryngoscope 119:107–115CrossRefPubMed Smith MC, Zimmerman MB, Burke DK et al (2009) Efficacy and safety of OK-432 immunotherapy of lymphatic malformations. Laryngoscope 119:107–115CrossRefPubMed
33.
go back to reference Greinwald JH Jr, Burke DK, Sato Y et al (1999) Treatment of lymphangiomas in children: an update of Picibanil (OK-432) sclerotherapy. Otolaryngol Head Neck Surg 121:381–387CrossRefPubMed Greinwald JH Jr, Burke DK, Sato Y et al (1999) Treatment of lymphangiomas in children: an update of Picibanil (OK-432) sclerotherapy. Otolaryngol Head Neck Surg 121:381–387CrossRefPubMed
38.
go back to reference Ghaffarpour N, Petrini B, Svensson LA et al (2015) Patients with lymphatic malformations who receive the immunostimulant OK-432 experience excellent long-term outcomes. Acta Paediatr Int J Paediatr 104:1169–1173CrossRef Ghaffarpour N, Petrini B, Svensson LA et al (2015) Patients with lymphatic malformations who receive the immunostimulant OK-432 experience excellent long-term outcomes. Acta Paediatr Int J Paediatr 104:1169–1173CrossRef
41.
go back to reference Ghaffarpour N, Claesson G, Wester T, Boman KK (2019) Long-term health-related quality of life in children with lymphatic malformations treated with sclerotherapy generally matched age-appropriate standardised population norms. Acta Paediatr (Oslo, Norway: 1992) 108:1499–1506. https://doi.org/10.1111/apa.14700CrossRef Ghaffarpour N, Claesson G, Wester T, Boman KK (2019) Long-term health-related quality of life in children with lymphatic malformations treated with sclerotherapy generally matched age-appropriate standardised population norms. Acta Paediatr (Oslo, Norway: 1992) 108:1499–1506. https://​doi.​org/​10.​1111/​apa.​14700CrossRef
Metadata
Title
Surgery versus sclerotherapy versus combined therapy in head and neck lymphatic malformations in the pediatric population: systematic review and meta-analysis
Authors
Jurriën L. A. Embrechts
Steven Hiddinga
Joseph C. Bot
Jan-Jaap Hendrickx
Rik van Eekelen
Johannes C. F. Ket
C. René Leemans
Remco de Bree
Publication date
07-05-2024
Publisher
Springer Berlin Heidelberg
Keyword
Sclerotherapy
Published in
European Archives of Oto-Rhino-Laryngology
Print ISSN: 0937-4477
Electronic ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-024-08661-6